U.S. markets open in 7 hours 47 minutes

Venus Concept Inc. (VERO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.1900-0.0900 (-7.03%)
At close: 04:00PM EST
1.2100 +0.02 (+1.68%)
After hours: 06:54PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.2800
Bid0.0000 x 2200
Ask0.0000 x 2900
Day's Range1.1900 - 1.3400
52 Week Range1.1900 - 3.4400
Avg. Volume210,339
Market Cap64.453M
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-0.6590
Earnings DateNov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for VERO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Venus Concept Inc.
    Analyst Report: Edwards Lifesciences CorporationSpun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • GlobeNewswire

    Venus Concept Announces Third Quarter and First Nine Months of 2021 Financial Results; Updates Fiscal Year 2021 Revenue Guidance

    TORONTO, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2021. Third Quarter 2021 Summary & Recent Highlights: Total revenue of $24.6 million, up $3.9 million, or 19%, year-over-year. U.S. revenue of $13.0 million, up $5.2 million, or 67%, year-over-year.Total subscription and system revenue of $20.7 million, up $3.7 m

  • GlobeNewswire

    Venus Concept Inc. to Participate in the Stifel 2021 Virtual Healthcare Conference

    TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2021 Virtual Healthcare Conference. Management will participate in a fireside chat at the conference on Wednesday, November 17th at 4:00 p.m. Eastern Time. An audio webcast of the presentation will be accessible under the “Events” section of the Company's investor relations web

  • Zacks

    Venus Concept (VERO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

    Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.